CHINA PETROLEUM & CHEMICAL CORP | CIK:0001123658 | 3

  • Filed: 4/27/2018
  • Entity registrant name: CHINA PETROLEUM & CHEMICAL CORP (CIK: 0001123658)
  • Generator: Merrill
  • SEC filing page: http://www.sec.gov/Archives/edgar/data/1123658/000110465918027339/0001104659-18-027339-index.htm
  • XBRL Instance: http://www.sec.gov/Archives/edgar/data/1123658/000110465918027339/snp-20171231.xml
  • XBRL Cloud Viewer: Click to open XBRL Cloud Viewer
  • EDGAR Dashboard: https://edgardashboard.xbrlcloud.com/edgar-dashboard/?cik=0001123658
  • Open this page in separate window: Click
  • ifrs-full:DescriptionOfAccountingPolicyForGoodwillExplanatory

    (j)     Goodwill

     

    Goodwill represents amounts arising on acquisition of subsidiaries, associates or joint ventures. Goodwill represents the difference between the cost of acquisition and the fair value of the net identifiable assets acquired.

     

    Prior to January 1, 2008, the acquisition of the non-controlling interests of a consolidated subsidiary was accounted for using the acquisition method whereby the difference between the cost of acquisition and the fair value of the net identifiable assets acquired (on a proportionate share) was recognized as goodwill. From January 1, 2008, any difference between the amount by which the non-controlling interest is adjusted (such as through an acquisition of the non-controlling interests) and the cash or other considerations paid is recognized in equity.

     

    Goodwill is stated at cost less accumulated impairment losses. Goodwill arising on a business combination is allocated to each cash-generating unit, or groups of cash-generating units, that is expected to benefit the synergies of the combination and is tested annually for impairment (Note 2(o)). In respect of associates or joint ventures, the carrying amount of goodwill is included in the carrying amount of the interest in the associates or joint ventures and the investment as a whole is tested for impairment whenever there is objective evidence of impairment (Note 2(o)).